Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Work In Process (2024 - 2025)

CorMedix's Work In Process history spans 2 years, with the latest figure at $11.7 million for Q4 2025.

  • For Q4 2025, Work In Process rose 231.38% year-over-year to $11.7 million; the TTM value through Dec 2025 reached $11.7 million, up 231.38%, while the annual FY2025 figure was $11.7 million, 231.38% up from the prior year.
  • Work In Process for Q4 2025 was $11.7 million at CorMedix, up from $9.1 million in the prior quarter.
  • Across five years, Work In Process topped out at $11.7 million in Q4 2025 and bottomed at $471415.0 in Q1 2024.